Quantum-Si Incorporated (including its subsidiaries, “Quantum-Si”, “QSI”, or the “Company”) was incorporated in Delaware on June 10, 2020 as HighCape Capital Acquisition Corp. (“HighCape”). The Company’s legal name became Quantum-Si Incorporated following a business combination on June 10, 2021 between the Company and Q-SI Operations Inc. (formerly Quantum-Si Incorporated) (the “Business Combination”), which was founded in 2013. We are a life sciences company focused on proteomics research, with the mission of transforming single-molecule analysis and democratizing its use by providing researchers and clinicians access to the proteome, the set of proteins expressed within a cell. We have developed a proprietary, universal, single-molecule detection platform that we are applying to proteomics to enable next-gen protein sequencing (“NGPS”) to sequence proteins in a massively parallel fashion (rather than sequentially, one at a time), which can also be used for the study of nucleic acids.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 0 | - | - | - | 0 |
| Net Income | -101M | -101M | -101M | -96M | -132M |
| EPS | $-0.51 | $-0.51 | $-0.71 | $-0.68 | $-0.95 |
| Free Cash Flow | -97M | -97M | -92M | -99M | -101M |
| ROIC | -46.2% | -46.0% | -46.9% | -35.3% | -36.9% |
| Gross Margin | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.12 | 0.15 | 0.10 | 0.09 |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | -116M | -116M | -109M | -111M | -124M |
| Operating Margin | 0.0% | - | - | - | - |
| ROE | -46.0% | -46.5% | -46.9% | -35.3% | -36.9% |
| Shares Outstanding | 199M | 199M | 142M | 141M | 139M |
| Metric | 2022 | 2023 | |||
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 0 | N/A | N/A | N/A | 0 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| R&D | 72M | 67M | 60M | 54M | 54M |
| SG&A | 42M | 45M | 51M | 45M | 45M |
| EBIT | -124M | -111M | -109M | -116M | -116M |
| Op. Margin | N/A | N/A | N/A | N/A | 0.0% |
| Net Income | -132M | -96M | -101M | -101M | -101M |
| Net Margin | N/A | N/A | N/A | N/A | 0.0% |
| Non-Recurring | 9.5M | 0 | 0 | 0 | 0 |
| Returns on Capital | |||||
| ROIC | -36.9% | -35.3% | -46.9% | -46.0% | -46.2% |
| ROE | -36.9% | -35.3% | -46.9% | -46.5% | -46.0% |
| ROA | -33.8% | -32.2% | -40.7% | -41.1% | -41.3% |
| Cash Flow | |||||
| Op. Cash Flow | -91M | -94M | -88M | -95M | -95M |
| Free Cash Flow | -101M | -99M | -92M | -97M | -97M |
| Owner Earnings | -104M | -107M | -101M | -110M | -110M |
| CapEx | 11M | 4.5M | 4.6M | 2.5M | 2.5M |
| Maint. CapEx | 2.6M | 4.2M | 4.6M | 4.5M | 4.5M |
| Growth CapEx | 8.2M | 354K | 0 | 0 | 0 |
| D&A | 2.6M | 4.2M | 4.6M | 4.5M | 4.5M |
| CapEx/OCF | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | 11M | 8.5M | 8.9M | 11M | 11M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | |||||
| Net Debt | N/A | N/A | N/A | N/A | -22M |
| Cash & Equiv. | 84M | 134M | 49M | 22M | 22M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Debt/Equity | 0.09 | 0.10 | 0.15 | 0.12 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A |
| Equity | 359M | 272M | 215M | 220M | 220M |
| Total Assets | 391M | 298M | 248M | 246M | 246M |
| Total Liabilities | 33M | 27M | 32M | 25M | 25M |
| Intangibles | 0 | 532K | 0 | N/A | N/A |
| Retained Earnings | -400M | -496M | -597M | -698M | -698M |
| Working Capital | 342M | 255M | 200M | 153M | 153M |
| Current Assets | 358M | 266M | 218M | 176M | 176M |
| Current Liabilities | 16M | 12M | 18M | 23M | 23M |
| Per Share Data | |||||
| EPS | -0.95 | -0.68 | -0.71 | -0.51 | -0.51 |
| Owner EPS | -0.75 | -0.76 | -0.71 | -0.55 | -0.55 |
| Book Value | 2.57 | 1.92 | 1.51 | 1.11 | 1.11 |
| Cash Flow/Share | -0.65 | -0.67 | -0.62 | -0.48 | -0.49 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 139.4M | 141.1M | 142.3M | 198.7M | 198.7M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | N/A | -1.6 |
| P/FCF | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A |
| Price/Book | 0.7 | 1.2 | 2.4 | 1.1 | 0.8 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | -39.5% | -30.8% | -18.0% | -39.8% | -58.2% |
| Market Cap | 257M | 320M | 512M | 244M | 167M |
| Avg. Price | 3.69 | 1.87 | 1.36 | 1.63 | 0.84 |
| Year-End Price | 1.84 | 2.27 | 3.60 | 1.23 | 0.84 |
Quantum-Si Inc passes 1 of 9 quality checks, indicating weak fundamentals.
At current prices, the estimated annualized return to fair value is +4.9%.
Quantum-Si Inc (QSI) has a 5-year average return on invested capital (ROIC) of -41.3%. This is below average and may indicate limited pricing power.
Quantum-Si Inc (QSI) has a market capitalization of $167M. It is classified as a small-cap stock.
Quantum-Si Inc (QSI) does not currently pay a regular dividend.
Quantum-Si Inc (QSI) operates in the Measuring & Controlling Devices, Nec industry, within the Technology sector.
Quantum-Si Inc (QSI) generated $-97 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Quantum-Si Inc (QSI) has a debt-to-equity ratio of 0.12. This indicates a conservatively financed balance sheet.
Quantum-Si Inc (QSI) reported earnings per share (EPS) of $-0.51 in its most recent fiscal year.
Quantum-Si Inc (QSI) has a return on equity (ROE) of -46.5%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 4 years of financial data for Quantum-Si Inc (QSI), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Quantum-Si Inc (QSI) has a book value per share of $1.11, based on its most recent annual SEC filing.
No recent press releases.